entertainment -WSS

entertainment

author：comprehensive 2025-08-26 02:49:16 - browse：99

Emma Walmsley on stage at the 2023 STAT Summit. — GSK CEO Emma Walmsley at the 2023 STAT Summit. STAT

The story of GSK is one of reinvention, CEO Emma Walmsley said at the STAT Summit in Boston on Thursday. Having shed its consumer division, the British drug giant is writing a new chapter as a pure-play biopharma company dedicated to the prevention, as well as treatment, of disease.

GSK’s recent launch of a new RSV vaccine for adults is emblematic of this move, adding to a portfolio that includes other vaccines, such as the very successful Shingrix for shingles, as well as drugs for HIV, other infectious diseases, and cancer, among others. But what does the growing sentiment against vaccination, not just in the United States but around the world, mean for such a bet on this market?

“It’s a very, very serious issue,” Walmsley said, noting that in 11 U.S. states, basic vaccination rates are now lower than they were before Covid. “The answer can’t be sort of flinging science over the airwaves and saying ‘trust us,’ because people don’t. There is a really serious challenge of misinformation and the ongoing issue of politicization, which I suspect is going to get more challenging in the next year for obvious reasons.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Senate panel passes drug pricing bills, but drops one PBM reform

WSS

Living organ donors deserve priority status for transplants

Novo pauses ads for weight loss drug Wegovy amid demand

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

A new ‘biological computer' targets cancer while sparing healthy cells

Stanford president’s abrupt resignation sparks debate

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

explore

entertainment

Wikipedia

Anesthesiologist group: stop taking Ozempic before surgery

Scientists grapple with ethics of stem cell research

Cancer drug shortages should be causing more outrage

Telehealth startups are trying to fill the menopause care vacuum

ChatGPT in medicine: STAT answers readers' burning questions

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Anesthesiologist group: stop taking Ozempic before surgery

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Heart attack and stroke risk calculators need revising

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

hotspot

A new ‘biological computer' targets cancer while sparing healthy cells

There’s a way to spot data fakery. All journals should be using it

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

After a decade, new Gardasil ad campaign gets it (mostly) right

Novo pauses ads for weight loss drug Wegovy amid demand

Xenotransplantation trials will require adjusting expectations, experts say

explore

focus

focus

explore